IXICO, HeiQ, Creo Medical, GlaxoSmithKline, Totally, Advanced Oncotherapy, Arecor Therapeutics, Midatech Pharma, Futura Medical, Yourgene Health, Renalytix, Polarean Imaging, Diurnal, Novacyt, Faron Pharmaceuticals, Poolbeg Pharma, ANGLE

29 Apr 2022
Cenkos: Healthcare Sector -- Ward Round
Agronomics Limited (ANIC:LON), 10.2 | RUA Life Sciences Plc (RUA:LON), 41.0 | Creo Medical Group Plc (CREO:LON), 24.6 | GENinCode PLC (GENI:LON), 13.5 | HeiQ PLC (HEIQ:LON), 20.2 | Inspiration Healthcare Group PLC (IHC:LON), 45.0 | IXICO Plc (IXI:LON), 20.0 | Intelligent Ultrasound Group Plc (IUG:LON), 11.0 | SkinBioTherapeutics Plc (SBTX:LON), 15.8 | ValiRx PLC (VAL:LON), 9.2 | Venture Life Group Plc (VLG:LON), 37.2 | OptiBiotix Health PLC (OPTI:LON), 8.4
-
-
-
Chris Donnellan | Edward Jinks
-
7 pages
-

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Healthcare Sector -- Ward Round
Agronomics Limited (ANIC:LON), 10.2 | RUA Life Sciences Plc (RUA:LON), 41.0 | Creo Medical Group Plc (CREO:LON), 24.6 | GENinCode PLC (GENI:LON), 13.5 | HeiQ PLC (HEIQ:LON), 20.2 | Inspiration Healthcare Group PLC (IHC:LON), 45.0 | IXICO Plc (IXI:LON), 20.0 | Intelligent Ultrasound Group Plc (IUG:LON), 11.0 | SkinBioTherapeutics Plc (SBTX:LON), 15.8 | ValiRx PLC (VAL:LON), 9.2 | Venture Life Group Plc (VLG:LON), 37.2 | OptiBiotix Health PLC (OPTI:LON), 8.4
- Published:
29 Apr 2022 -
Author:
Chris Donnellan | Edward Jinks -
Pages:
7 -
IXICO, HeiQ, Creo Medical, GlaxoSmithKline, Totally, Advanced Oncotherapy, Arecor Therapeutics, Midatech Pharma, Futura Medical, Yourgene Health, Renalytix, Polarean Imaging, Diurnal, Novacyt, Faron Pharmaceuticals, Poolbeg Pharma, ANGLE